Facebook Linkedin RSS Twitter Youtube
Home 2024

Phase II clinical trials (Clinical trial)

MinervaX and Wacker Collaborate on Manufacturing Prophylactic Group B Streptococcus Vaccine
Bioprocessing

MinervaX and Wacker Collaborate on Manufacturing Prophylactic Group B Streptococcus Vaccine

StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial
Drug Discovery

StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial

StockWatch: Neurocrine Tumbles as Schizophrenia Data Disappoints
Drug Discovery

StockWatch: Neurocrine Tumbles as Schizophrenia Data Disappoints

TRACT Transfers Its Regulatory T Cell Platform Technology to Taiwan Bio’s Manufacturing Facility
Bioprocessing

TRACT Transfers Its Regulatory T Cell Platform Technology to Taiwan Bio’s Manufacturing Facility

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data
Drug Discovery

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data

AI Drug Discovery Company Healx Raises $47M, Cleared to Test Neurofibromatosis Drug
Artificial Intelligence

AI Drug Discovery Company Healx Raises $47M, Cleared to Test Neurofibromatosis Drug

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths
Cancer

FDA Imposes Partial Hold on BioNTech/MedLink ADC Trial after Three Patient Deaths

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

Insilico Doses First Patient with AI-Designed IBD Treatment
Artificial Intelligence

Insilico Doses First Patient with AI-Designed IBD Treatment

Immune Cell Therapy May Become More Naturalistic
Cancer

Immune Cell Therapy May Become More Naturalistic

123...21Page 1 of 21
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.